{"transactions":[{"id":731251,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-06-22T20:22:23.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6000,"derivative":{"exercise_price":1.18,"exercise_date":"2027-06-17","expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001437749-26-021323","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774926021323/rdgdoc.xml","form_type":"4"}},{"id":731250,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36560,"kind":"person","name":"Morgan Jayne","position":1,"cik":"0001959682","reported_name":"Morgan Jayne","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-06-22T20:21:40.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6000,"derivative":{"exercise_price":1.18,"exercise_date":"2027-06-17","expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001437749-26-021322","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774926021322/rdgdoc.xml","form_type":"4"}},{"id":731249,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36559,"kind":"person","name":"MCNALLY ROBERT T","position":1,"cik":"0001049435","reported_name":"MCNALLY ROBERT T","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-06-22T20:21:09.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6000,"derivative":{"exercise_price":1.18,"exercise_date":"2027-06-17","expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001437749-26-021321","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774926021321/rdgdoc.xml","form_type":"4"}},{"id":731248,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":35347,"kind":"person","name":"Lemerond Nicole","position":1,"cik":"0001941712","reported_name":"Lemerond Nicole","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-06-22T20:20:38.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6000,"derivative":{"exercise_price":1.18,"exercise_date":"2027-06-17","expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001437749-26-021320","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774926021320/rdgdoc.xml","form_type":"4"}},{"id":731247,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36558,"kind":"person","name":"Kollintzas Dean G","position":1,"cik":"0001378351","reported_name":"Kollintzas Dean G","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-06-22T20:20:05.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6000,"derivative":{"exercise_price":1.18,"exercise_date":"2027-06-17","expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001437749-26-021319","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774926021319/rdgdoc.xml","form_type":"4"}},{"id":731246,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36557,"kind":"person","name":"CHASE RANDAL D","position":1,"cik":"0001078784","reported_name":"CHASE RANDAL D","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-06-22T20:19:30.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6000,"derivative":{"exercise_price":1.18,"exercise_date":"2027-06-17","expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001437749-26-021317","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774926021317/rdgdoc.xml","form_type":"4"}},{"id":731245,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36556,"kind":"person","name":"Sharkey John W.","position":1,"cik":"0001515991","reported_name":"Sharkey John W.","relationship":{"officer":true,"officer_title":"VP, Business Development"}}],"security":"Stock Option","published_at":"2026-06-22T20:19:01.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":17600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":17600,"derivative":{"exercise_price":1.18,"expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":17600},"source":{"system":"sec-edgar","filing":"0001437749-26-021316","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774926021316/rdgdoc.xml","form_type":"4"}},{"id":731244,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36555,"kind":"person","name":"Reynolds Mark","position":1,"cik":"0001298237","reported_name":"Reynolds Mark","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Stock Option","published_at":"2026-06-22T20:18:31.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":17600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":17600,"derivative":{"exercise_price":1.18,"expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":17600},"source":{"system":"sec-edgar","filing":"0001437749-26-021315","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774926021315/rdgdoc.xml","form_type":"4"}},{"id":731243,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36554,"kind":"person","name":"NEWMAN MARK J","position":1,"cik":"0001242123","reported_name":"NEWMAN MARK J","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option","published_at":"2026-06-22T20:18:01.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":17600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":17600,"derivative":{"exercise_price":1.18,"expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":17600},"source":{"system":"sec-edgar","filing":"0001437749-26-021314","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774926021314/rdgdoc.xml","form_type":"4"}},{"id":731242,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36553,"kind":"person","name":"McKee Kelly T. Jr.","position":1,"cik":"0001903889","reported_name":"McKee Kelly T. Jr.","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-06-22T20:17:29.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":17600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":17600,"derivative":{"exercise_price":1.18,"expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":17600},"source":{"system":"sec-edgar","filing":"0001437749-26-021312","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774926021312/rdgdoc.xml","form_type":"4"}},{"id":731241,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36552,"kind":"person","name":"DODD DAVID A","position":1,"cik":"0001193607","reported_name":"DODD DAVID A","relationship":{"director":true,"officer":true,"officer_title":"President, CEO"}}],"security":"Stock Option","published_at":"2026-06-22T20:16:53.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":29300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":29300,"derivative":{"exercise_price":1.18,"expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":29300},"source":{"system":"sec-edgar","filing":"0001437749-26-021311","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774926021311/rdgdoc.xml","form_type":"4"}},{"id":1016129,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-10-20T13:11:05.000Z","date":"2025-10-17","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.5498,"value":5498.0,"ownership":{"direct":true},"balance_after":21402,"source":{"system":"sec-edgar","filing":"0001437749-25-031314","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774925031314/rdgdoc.xml","form_type":"4"}},{"id":1071845,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36553,"kind":"person","name":"McKee Kelly T. Jr.","position":1,"cik":"0001903889","reported_name":"McKee Kelly T. Jr.","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-08-08T19:13:56.000Z","date":"2025-08-07","kind":"purchase","planned":false,"acquired":true,"shares":1107,"price":0.67,"value":741.69,"ownership":{"direct":true},"balance_after":3494,"source":{"system":"sec-edgar","filing":"0001437749-25-025690","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774925025690/rdgdoc.xml","form_type":"4"}},{"id":1120475,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":35347,"kind":"person","name":"Lemerond Nicole","position":1,"cik":"0001941712","reported_name":"Lemerond Nicole","relationship":{"director":true}}],"security":"Stock Option","published_at":"2025-06-06T13:51:40.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted on January 2, 2025, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of the GeoVax Labs, Inc. 2025 Stock Incentive Plan.  Such approval occurred on June 5, 2025, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."}],"balance_after":10000,"derivative":{"exercise_price":2.48,"exercise_date":"2026-01-02","expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-25-019644","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774925019644/rdgdoc.xml","form_type":"4"}},{"id":1120474,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36557,"kind":"person","name":"CHASE RANDAL D","position":1,"cik":"0001078784","reported_name":"CHASE RANDAL D","relationship":{"director":true}}],"security":"Stock Option","published_at":"2025-06-06T13:50:36.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted on January 2, 2025, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of the GeoVax Labs, Inc. 2025 Stock Incentive Plan.  Such approval occurred on June 5, 2025, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."}],"balance_after":10000,"derivative":{"exercise_price":2.48,"exercise_date":"2026-01-02","expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-25-019642","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774925019642/rdgdoc.xml","form_type":"4"}},{"id":1120473,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36558,"kind":"person","name":"Kollintzas Dean G","position":1,"cik":"0001378351","reported_name":"Kollintzas Dean G","relationship":{"director":true}}],"security":"Stock Option","published_at":"2025-06-06T13:49:19.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted on January 2, 2025, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of the GeoVax Labs, Inc. 2025 Stock Incentive Plan.  Such approval occurred on June 5, 2025, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."}],"balance_after":10000,"derivative":{"exercise_price":2.48,"exercise_date":"2026-01-02","expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-25-019640","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774925019640/rdgdoc.xml","form_type":"4"}},{"id":1120471,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36559,"kind":"person","name":"MCNALLY ROBERT T","position":1,"cik":"0001049435","reported_name":"MCNALLY ROBERT T","relationship":{"director":true}}],"security":"Stock Option","published_at":"2025-06-06T13:48:00.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted on January 2, 2025, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of the GeoVax Labs, Inc. 2025 Stock Incentive Plan.  Such approval occurred on June 5, 2025, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."}],"balance_after":10000,"derivative":{"exercise_price":2.48,"exercise_date":"2026-01-02","expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-25-019638","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774925019638/rdgdoc.xml","form_type":"4"}},{"id":1120472,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36560,"kind":"person","name":"Morgan Jayne","position":1,"cik":"0001959682","reported_name":"Morgan Jayne","relationship":{"director":true}}],"security":"Stock Option","published_at":"2025-06-06T13:46:35.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted on January 2, 2025, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of the GeoVax Labs, Inc. 2025 Stock Incentive Plan.  Such approval occurred on June 5, 2025, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."}],"balance_after":10000,"derivative":{"exercise_price":2.48,"exercise_date":"2026-01-02","expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-25-019636","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774925019636/rdgdoc.xml","form_type":"4"}},{"id":1120469,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true}}],"security":"Stock Option","published_at":"2025-06-06T13:45:09.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted on January 2, 2025, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of the GeoVax Labs, Inc. 2025 Stock Incentive Plan.  Such approval occurred on June 5, 2025, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."}],"balance_after":10000,"derivative":{"exercise_price":2.48,"exercise_date":"2026-01-02","expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-25-019634","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774925019634/rdgdoc.xml","form_type":"4"}},{"id":1120470,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36554,"kind":"person","name":"NEWMAN MARK J","position":1,"cik":"0001242123","reported_name":"NEWMAN MARK J","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option","published_at":"2025-06-06T13:42:55.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"This stock option was granted on January 2, 2025, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of the GeoVax Labs, Inc. 2025 Stock Incentive Plan.  Such approval occurred on June 5, 2025, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":70000,"derivative":{"exercise_price":2.48,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001437749-25-019632","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774925019632/rdgdoc.xml","form_type":"4"}},{"id":1120468,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36553,"kind":"person","name":"McKee Kelly T. Jr.","position":1,"cik":"0001903889","reported_name":"McKee Kelly T. Jr.","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2025-06-06T13:41:08.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"This stock option was granted on January 2, 2025, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of the GeoVax Labs, Inc. 2025 Stock Incentive Plan.  Such approval occurred on June 5, 2025, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":70000,"derivative":{"exercise_price":2.48,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001437749-25-019630","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774925019630/rdgdoc.xml","form_type":"4"}},{"id":1120467,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36556,"kind":"person","name":"Sharkey John W.","position":1,"cik":"0001515991","reported_name":"Sharkey John W.","relationship":{"officer":true,"officer_title":"VP, Business Development"}}],"security":"Stock Option","published_at":"2025-06-06T13:39:54.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"This stock option was granted on January 2, 2025, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of the GeoVax Labs, Inc. 2025 Stock Incentive Plan.  Such approval occurred on June 5, 2025, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":70000,"derivative":{"exercise_price":2.48,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001437749-25-019628","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774925019628/rdgdoc.xml","form_type":"4"}},{"id":1120466,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36555,"kind":"person","name":"Reynolds Mark","position":1,"cik":"0001298237","reported_name":"Reynolds Mark","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Stock Option","published_at":"2025-06-06T13:38:09.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"This stock option was granted on January 2, 2025, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of the GeoVax Labs, Inc. 2025 Stock Incentive Plan.  Such approval occurred on June 5, 2025, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":70000,"derivative":{"exercise_price":2.48,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001437749-25-019626","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774925019626/rdgdoc.xml","form_type":"4"}},{"id":1120465,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36552,"kind":"person","name":"DODD DAVID A","position":1,"cik":"0001193607","reported_name":"DODD DAVID A","relationship":{"director":true,"officer":true,"officer_title":"President, CEO"}}],"security":"Stock Option","published_at":"2025-06-06T13:35:39.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":185500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"This stock option was granted on January 2, 2025, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of the GeoVax Labs, Inc. 2025 Stock Incentive Plan.  Such approval occurred on June 5, 2025, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":185500,"derivative":{"exercise_price":2.48,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":185500},"source":{"system":"sec-edgar","filing":"0001437749-25-019624","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774925019624/rdgdoc.xml","form_type":"4"}},{"id":1173654,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-04-11T17:23:33.000Z","date":"2025-04-10","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.98,"value":9800.0,"ownership":{"direct":true},"balance_after":11402,"source":{"system":"sec-edgar","filing":"0001437749-25-011750","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774925011750/rdgdoc.xml","form_type":"4"}},{"id":1174354,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36556,"kind":"person","name":"Sharkey John W.","position":1,"cik":"0001515991","reported_name":"Sharkey John W.","relationship":{"officer":true,"officer_title":"VP, Business Development"}}],"security":"Common Stock","published_at":"2025-04-10T20:01:15.000Z","date":"2025-04-10","kind":"purchase","planned":false,"acquired":true,"shares":6000,"price":0.99,"value":5940.0,"ownership":{"direct":true},"balance_after":6191,"source":{"system":"sec-edgar","filing":"0001437749-25-011658","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774925011658/rdgdoc.xml","form_type":"4"}},{"id":1187279,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36552,"kind":"person","name":"DODD DAVID A","position":1,"cik":"0001193607","reported_name":"DODD DAVID A","relationship":{"director":true,"officer":true,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-04-01T20:46:16.000Z","date":"2025-04-01","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.08,"value":10800.0,"ownership":{"direct":true},"balance_after":36661,"source":{"system":"sec-edgar","filing":"0001437749-25-010482","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774925010482/rdgdoc.xml","form_type":"4"}},{"id":1188472,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36555,"kind":"person","name":"Reynolds Mark","position":1,"cik":"0001298237","reported_name":"Reynolds Mark","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-03-31T20:04:27.000Z","date":"2025-03-31","kind":"purchase","planned":false,"acquired":true,"shares":6800,"price":1.0799,"value":7343.32,"ownership":{"direct":true},"balance_after":14013,"source":{"system":"sec-edgar","filing":"0001437749-25-010179","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774925010179/rdgdoc.xml","form_type":"4"}},{"id":1434199,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36552,"kind":"person","name":"DODD DAVID A","position":1,"cik":"0001193607","reported_name":"DODD DAVID A","relationship":{"director":true,"officer":true,"officer_title":"President, CEO"}}],"security":"Stock Option","published_at":"2024-08-14T20:12:03.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments on the first three anniversary dates of the grant."}],"balance_after":35000,"derivative":{"exercise_price":2.17,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001437749-24-026813","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774924026813/rdgdoc.xml","form_type":"4"}},{"id":1434198,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36553,"kind":"person","name":"McKee Kelly T. Jr.","position":1,"cik":"0001903889","reported_name":"McKee Kelly T. Jr.","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2024-08-14T20:11:26.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":15700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments on the first three anniversary dates of the grant."}],"balance_after":15700,"derivative":{"exercise_price":2.17,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":15700},"source":{"system":"sec-edgar","filing":"0001437749-24-026809","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774924026809/rdgdoc.xml","form_type":"4"}},{"id":1434197,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36554,"kind":"person","name":"NEWMAN MARK J","position":1,"cik":"0001242123","reported_name":"NEWMAN MARK J","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option","published_at":"2024-08-14T20:10:52.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":15700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments on the first three anniversary dates of the grant."}],"balance_after":15700,"derivative":{"exercise_price":2.17,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":15700},"source":{"system":"sec-edgar","filing":"0001437749-24-026804","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774924026804/rdgdoc.xml","form_type":"4"}},{"id":1434196,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36555,"kind":"person","name":"Reynolds Mark","position":1,"cik":"0001298237","reported_name":"Reynolds Mark","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Stock Option","published_at":"2024-08-14T20:10:18.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":15700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments on the first three anniversary dates of the grant."}],"balance_after":15700,"derivative":{"exercise_price":2.17,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":15700},"source":{"system":"sec-edgar","filing":"0001437749-24-026802","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774924026802/rdgdoc.xml","form_type":"4"}},{"id":1434195,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36556,"kind":"person","name":"Sharkey John W.","position":1,"cik":"0001515991","reported_name":"Sharkey John W.","relationship":{"officer":true,"officer_title":"VP, Business Development"}}],"security":"Stock Option","published_at":"2024-08-14T20:09:46.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":15700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments on the first three anniversary dates of the grant."}],"balance_after":15700,"derivative":{"exercise_price":2.17,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":15700},"source":{"system":"sec-edgar","filing":"0001437749-24-026800","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774924026800/rdgdoc.xml","form_type":"4"}},{"id":1434194,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36557,"kind":"person","name":"CHASE RANDAL D","position":1,"cik":"0001078784","reported_name":"CHASE RANDAL D","relationship":{"director":true}}],"security":"Stock Option","published_at":"2024-08-14T20:09:05.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":8050,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8050,"derivative":{"exercise_price":2.17,"exercise_date":"2025-08-12","expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":8050},"source":{"system":"sec-edgar","filing":"0001437749-24-026798","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774924026798/rdgdoc.xml","form_type":"4"}},{"id":1434193,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36558,"kind":"person","name":"Kollintzas Dean G","position":1,"cik":"0001378351","reported_name":"Kollintzas Dean G","relationship":{"director":true}}],"security":"Stock Option","published_at":"2024-08-14T20:08:32.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":8050,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8050,"derivative":{"exercise_price":2.17,"exercise_date":"2025-08-12","expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":8050},"source":{"system":"sec-edgar","filing":"0001437749-24-026793","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774924026793/rdgdoc.xml","form_type":"4"}},{"id":1434192,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":35347,"kind":"person","name":"Lemerond Nicole","position":1,"cik":"0001941712","reported_name":"Lemerond Nicole","relationship":{"director":true}}],"security":"Stock Option","published_at":"2024-08-14T20:07:59.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":8050,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8050,"derivative":{"exercise_price":2.17,"exercise_date":"2025-08-12","expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":8050},"source":{"system":"sec-edgar","filing":"0001437749-24-026791","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774924026791/rdgdoc.xml","form_type":"4"}},{"id":1434191,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36559,"kind":"person","name":"MCNALLY ROBERT T","position":1,"cik":"0001049435","reported_name":"MCNALLY ROBERT T","relationship":{"director":true}}],"security":"Stock Option","published_at":"2024-08-14T20:07:23.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":8050,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8050,"derivative":{"exercise_price":2.17,"exercise_date":"2025-08-12","expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":8050},"source":{"system":"sec-edgar","filing":"0001437749-24-026788","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774924026788/rdgdoc.xml","form_type":"4"}},{"id":1434190,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36560,"kind":"person","name":"Morgan Jayne","position":1,"cik":"0001959682","reported_name":"Morgan Jayne","relationship":{"director":true}}],"security":"Stock Option","published_at":"2024-08-14T20:06:50.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":8050,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8050,"derivative":{"exercise_price":2.17,"exercise_date":"2025-08-12","expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":8050},"source":{"system":"sec-edgar","filing":"0001437749-24-026787","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774924026787/rdgdoc.xml","form_type":"4"}},{"id":1434189,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true}}],"security":"Stock Option","published_at":"2024-08-14T20:06:04.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":8050,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8050,"derivative":{"exercise_price":2.17,"exercise_date":"2025-08-12","expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":8050},"source":{"system":"sec-edgar","filing":"0001437749-24-026786","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774924026786/rdgdoc.xml","form_type":"4"}},{"id":1436402,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36552,"kind":"person","name":"DODD DAVID A","position":1,"cik":"0001193607","reported_name":"DODD DAVID A","relationship":{"director":true,"officer":true,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2024-08-12T12:47:49.000Z","date":"2024-08-09","kind":"purchase","planned":false,"acquired":true,"shares":8000,"price":1.95,"value":15600.0,"ownership":{"direct":true},"balance_after":26661,"source":{"system":"sec-edgar","filing":"0001437749-24-025953","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774924025953/rdgdoc.xml","form_type":"4"}},{"id":1626899,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36552,"kind":"person","name":"DODD DAVID A","position":1,"cik":"0001193607","reported_name":"DODD DAVID A","relationship":{"director":true,"officer":true,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2024-02-22T21:41:26.000Z","date":"2024-02-22","kind":"purchase","planned":false,"acquired":true,"shares":8209,"price":2.2735,"value":18663.1615,"ownership":{"direct":true},"balance_after":18661,"source":{"system":"sec-edgar","filing":"0001437749-24-005209","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774924005209/rdgdoc.xml","form_type":"4"}},{"id":1626898,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36552,"kind":"person","name":"DODD DAVID A","position":1,"cik":"0001193607","reported_name":"DODD DAVID A","relationship":{"director":true,"officer":true,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2024-02-22T21:41:26.000Z","date":"2024-02-21","kind":"purchase","planned":false,"acquired":true,"shares":520,"price":2.15,"value":1118.0,"ownership":{"direct":true},"balance_after":10452,"source":{"system":"sec-edgar","filing":"0001437749-24-005209","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774924005209/rdgdoc.xml","form_type":"4"}},{"id":1655963,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36555,"kind":"person","name":"Reynolds Mark","position":1,"cik":"0001298237","reported_name":"Reynolds Mark","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-02-07T21:43:48.000Z","date":"2024-02-07","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":2.77,"value":5540.0,"ownership":{"direct":true},"balance_after":7213,"source":{"system":"sec-edgar","filing":"0001437749-24-003380","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774924003380/rdgdoc.xml","form_type":"4"}},{"id":1700470,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36553,"kind":"person","name":"McKee Kelly T. Jr.","position":1,"cik":"0001903889","reported_name":"McKee Kelly T. Jr.","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-12-26T20:51:34.000Z","date":"2023-12-22","kind":"purchase","planned":false,"acquired":true,"shares":6944,"price":0.36,"value":2499.84,"ownership":{"direct":true},"balance_after":35782,"source":{"system":"sec-edgar","filing":"0001437749-23-035306","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774923035306/rdgdoc.xml","form_type":"4"}},{"id":1772932,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36553,"kind":"person","name":"McKee Kelly T. Jr.","position":1,"cik":"0001903889","reported_name":"McKee Kelly T. Jr.","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-09-27T20:33:08.000Z","date":"2023-09-25","kind":"purchase","planned":false,"acquired":true,"shares":9653,"price":0.52,"value":5019.56,"ownership":{"direct":true},"balance_after":28838,"source":{"system":"sec-edgar","filing":"0001437749-23-026935","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774923026935/rdgdoc.xml","form_type":"4"}},{"id":1795774,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36552,"kind":"person","name":"DODD DAVID A","position":1,"cik":"0001193607","reported_name":"DODD DAVID A","relationship":{"director":true,"officer":true,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-08-28T20:05:26.000Z","date":"2023-08-25","kind":"purchase","planned":false,"acquired":true,"shares":35087,"price":0.57,"value":19999.59,"ownership":{"direct":true},"balance_after":148957,"source":{"system":"sec-edgar","filing":"0001437749-23-024763","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774923024763/rdgdoc.xml","form_type":"4"}},{"id":1801204,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36555,"kind":"person","name":"Reynolds Mark","position":1,"cik":"0001298237","reported_name":"Reynolds Mark","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-08-21T12:39:37.000Z","date":"2023-08-18","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.5179,"value":5179.0,"ownership":{"direct":true},"balance_after":78184,"source":{"system":"sec-edgar","filing":"0001437749-23-024227","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774923024227/rdgdoc.xml","form_type":"4"}},{"id":1809185,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true}}],"security":"Stock Option","published_at":"2023-08-14T20:53:51.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted on December 7, 2022, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan.  Such approval occurred on August 1, 2023, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."}],"balance_after":50000,"derivative":{"exercise_price":0.755,"exercise_date":"2023-12-07","expiration_date":"2033-12-07","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-23-023746","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774923023746/rdgdoc.xml","form_type":"4"}},{"id":1809184,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36560,"kind":"person","name":"Morgan Jayne","position":1,"cik":"0001959682","reported_name":"Morgan Jayne","relationship":{"director":true}}],"security":"Stock Option","published_at":"2023-08-14T20:53:17.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted on December 7, 2022, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan.  Such approval occurred on August 1, 2023, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."}],"balance_after":50000,"derivative":{"exercise_price":0.755,"exercise_date":"2023-12-07","expiration_date":"2033-12-07","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-23-023745","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774923023745/rdgdoc.xml","form_type":"4"}},{"id":1809183,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36559,"kind":"person","name":"MCNALLY ROBERT T","position":1,"cik":"0001049435","reported_name":"MCNALLY ROBERT T","relationship":{"director":true}}],"security":"Stock Option","published_at":"2023-08-14T20:52:44.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted on December 7, 2022, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan.  Such approval occurred on August 1, 2023, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."}],"balance_after":50000,"derivative":{"exercise_price":0.755,"exercise_date":"2023-12-07","expiration_date":"2033-12-07","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-23-023744","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774923023744/rdgdoc.xml","form_type":"4"}},{"id":1809182,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":35347,"kind":"person","name":"Lemerond Nicole","position":1,"cik":"0001941712","reported_name":"Lemerond Nicole","relationship":{"director":true}}],"security":"Stock Option","published_at":"2023-08-14T20:52:05.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted on December 7, 2022, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan.  Such approval occurred on August 1, 2023, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."}],"balance_after":50000,"derivative":{"exercise_price":0.755,"exercise_date":"2023-12-07","expiration_date":"2033-12-07","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-23-023741","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774923023741/rdgdoc.xml","form_type":"4"}},{"id":1809181,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36558,"kind":"person","name":"Kollintzas Dean G","position":1,"cik":"0001378351","reported_name":"Kollintzas Dean G","relationship":{"director":true}}],"security":"Stock Option","published_at":"2023-08-14T20:51:33.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted on December 7, 2022, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan.  Such approval occurred on August 1, 2023, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."}],"balance_after":50000,"derivative":{"exercise_price":0.755,"exercise_date":"2023-12-07","expiration_date":"2033-12-07","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-23-023739","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774923023739/rdgdoc.xml","form_type":"4"}},{"id":1809180,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36557,"kind":"person","name":"CHASE RANDAL D","position":1,"cik":"0001078784","reported_name":"CHASE RANDAL D","relationship":{"director":true}}],"security":"Stock Option","published_at":"2023-08-14T20:50:48.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted on December 7, 2022, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan.  Such approval occurred on August 1, 2023, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."}],"balance_after":50000,"derivative":{"exercise_price":0.755,"exercise_date":"2023-12-07","expiration_date":"2033-12-07","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-23-023738","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774923023738/rdgdoc.xml","form_type":"4"}},{"id":1809179,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36553,"kind":"person","name":"McKee Kelly T. Jr.","position":1,"cik":"0001903889","reported_name":"McKee Kelly T. Jr.","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2023-08-14T20:50:05.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted on December 7, 2022, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan.  Such approval occurred on August 1, 2023, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock option becomes exercisable in three equal annual installments on the first three anniversary dates of the grant."}],"balance_after":15000,"derivative":{"exercise_price":0.755,"expiration_date":"2033-12-07","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001437749-23-023737","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774923023737/rdgdoc.xml","form_type":"4"}},{"id":1809178,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36556,"kind":"person","name":"Sharkey John W.","position":1,"cik":"0001515991","reported_name":"Sharkey John W.","relationship":{"officer":true,"officer_title":"VP, Business Development"}}],"security":"Stock Option","published_at":"2023-08-14T20:49:31.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted on December 7, 2022, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan.  Such approval occurred on August 1, 2023, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock option becomes exercisable in three equal annual installments on the first three anniversary dates of the grant."}],"balance_after":100000,"derivative":{"exercise_price":0.755,"expiration_date":"2033-12-07","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-23-023736","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774923023736/rdgdoc.xml","form_type":"4"}},{"id":1809177,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36554,"kind":"person","name":"NEWMAN MARK J","position":1,"cik":"0001242123","reported_name":"NEWMAN MARK J","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option","published_at":"2023-08-14T20:48:49.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted on December 7, 2022, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan.  Such approval occurred on August 1, 2023, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock option becomes exercisable in three equal annual installments on the first three anniversary dates of the grant."}],"balance_after":100000,"derivative":{"exercise_price":0.755,"expiration_date":"2033-12-07","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-23-023733","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774923023733/rdgdoc.xml","form_type":"4"}},{"id":1809175,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36552,"kind":"person","name":"DODD DAVID A","position":1,"cik":"0001193607","reported_name":"DODD DAVID A","relationship":{"director":true,"officer":true,"officer_title":"President, CEO"}}],"security":"Stock Option","published_at":"2023-08-14T20:47:47.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted on December 7, 2022, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan.  Such approval occurred on August 1, 2023, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock option becomes exercisable in three equal annual installments on the first three anniversary dates of the grant."}],"balance_after":250000,"derivative":{"exercise_price":0.755,"expiration_date":"2033-12-07","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001437749-23-023731","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774923023731/rdgdoc.xml","form_type":"4"}},{"id":1809176,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36555,"kind":"person","name":"Reynolds Mark","position":1,"cik":"0001298237","reported_name":"Reynolds Mark","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Stock Option","published_at":"2023-08-14T20:46:40.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted on December 7, 2022, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan.  Such approval occurred on August 1, 2023, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock option becomes exercisable in three equal annual installments on the first three anniversary dates of the grant."}],"balance_after":100000,"derivative":{"exercise_price":0.755,"expiration_date":"2033-12-07","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-23-023727","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774923023727/rdgdoc.xml","form_type":"4"}},{"id":1914478,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36552,"kind":"person","name":"DODD DAVID A","position":1,"cik":"0001193607","reported_name":"DODD DAVID A","relationship":{"director":true,"officer":true,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-04-25T19:13:06.000Z","date":"2023-04-24","kind":"purchase","planned":false,"acquired":true,"shares":32000,"price":0.6389,"value":20444.8,"ownership":{"direct":true},"balance_after":113870,"source":{"system":"sec-edgar","filing":"0001437749-23-011000","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774923011000/rdgdoc.xml","form_type":"4"}},{"id":1915942,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36555,"kind":"person","name":"Reynolds Mark","position":1,"cik":"0001298237","reported_name":"Reynolds Mark","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-04-21T12:38:42.000Z","date":"2023-04-20","kind":"purchase","planned":false,"acquired":true,"shares":8000,"price":0.63,"value":5040.0,"ownership":{"direct":true},"balance_after":68184,"source":{"system":"sec-edgar","filing":"0001437749-23-010776","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774923010776/rdgdoc.xml","form_type":"4"}},{"id":2152329,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36557,"kind":"person","name":"CHASE RANDAL D","position":1,"cik":"0001078784","reported_name":"CHASE RANDAL D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-09-23T15:24:45.000Z","date":"2022-09-21","kind":"purchase","acquired":true,"shares":10000,"price":1.1,"value":11000.0,"ownership":{"direct":true},"balance_after":36613,"source":{"system":"sec-edgar","filing":"0001437749-22-022942","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774922022942/rdgdoc.xml","form_type":"4"}},{"id":2215921,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36556,"kind":"person","name":"Sharkey John W.","position":1,"cik":"0001515991","reported_name":"Sharkey John W.","relationship":{"officer":true,"officer_title":"VP, Business Development"}}],"security":"Common Stock","published_at":"2022-07-05T19:10:00.000Z","date":"2022-07-01","kind":"purchase","acquired":true,"shares":1000,"price":0.82,"value":820.0,"ownership":{"direct":true},"balance_after":2860,"source":{"system":"sec-edgar","filing":"0001437749-22-016567","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774922016567/rdgdoc.xml","form_type":"4"}},{"id":2220579,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36553,"kind":"person","name":"McKee Kelly T. Jr.","position":1,"cik":"0001903889","reported_name":"McKee Kelly T. Jr.","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-06-28T18:59:28.000Z","date":"2022-06-27","kind":"purchase","acquired":true,"shares":4464,"price":1.12,"value":4999.68,"ownership":{"direct":true},"balance_after":19185,"source":{"system":"sec-edgar","filing":"0001437749-22-016072","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774922016072/rdgdoc.xml","form_type":"4"}},{"id":2224654,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36557,"kind":"person","name":"CHASE RANDAL D","position":1,"cik":"0001078784","reported_name":"CHASE RANDAL D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-06-22T12:53:05.000Z","date":"2022-06-21","kind":"purchase","acquired":true,"shares":10000,"price":1.21,"value":12100.0,"ownership":{"direct":true},"balance_after":26613,"source":{"system":"sec-edgar","filing":"0001437749-22-015552","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774922015552/rdgdoc.xml","form_type":"4"}},{"id":2279905,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36553,"kind":"person","name":"McKee Kelly T. Jr.","position":1,"cik":"0001903889","reported_name":"McKee Kelly T. Jr.","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-05-06T15:13:37.000Z","date":"2022-05-05","kind":"purchase","acquired":true,"shares":9722,"price":0.72,"value":6999.84,"ownership":{"direct":true},"balance_after":14721,"source":{"system":"sec-edgar","filing":"0001437749-22-011257","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774922011257/rdgdoc.xml","form_type":"4"}},{"id":2281317,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36553,"kind":"person","name":"McKee Kelly T. Jr.","position":1,"cik":"0001903889","reported_name":"McKee Kelly T. Jr.","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-05-05T20:23:59.000Z","date":"2022-05-04","kind":"purchase","acquired":true,"shares":4999,"price":0.71,"value":3549.29,"ownership":{"direct":true},"balance_after":4999,"source":{"system":"sec-edgar","filing":"0001437749-22-011137","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774922011137/rdgdoc.xml","form_type":"4"}},{"id":2481333,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-12-08T22:24:20.000Z","date":"2021-12-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":3.82,"exercise_date":"2022-12-07","expiration_date":"2031-12-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-21-028134","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774921028134/rdgdoc.xml","form_type":"4"}},{"id":2481332,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36559,"kind":"person","name":"MCNALLY ROBERT T","position":1,"cik":"0001049435","reported_name":"MCNALLY ROBERT T","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-12-08T22:23:29.000Z","date":"2021-12-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":3.82,"exercise_date":"2022-12-07","expiration_date":"2031-12-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-21-028133","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774921028133/rdgdoc.xml","form_type":"4"}},{"id":2481331,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36558,"kind":"person","name":"Kollintzas Dean G","position":1,"cik":"0001378351","reported_name":"Kollintzas Dean G","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-12-08T22:22:44.000Z","date":"2021-12-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":3.82,"exercise_date":"2022-12-07","expiration_date":"2031-12-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-21-028132","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774921028132/rdgdoc.xml","form_type":"4"}},{"id":2481330,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36557,"kind":"person","name":"CHASE RANDAL D","position":1,"cik":"0001078784","reported_name":"CHASE RANDAL D","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-12-08T22:22:04.000Z","date":"2021-12-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":3.82,"exercise_date":"2022-12-07","expiration_date":"2031-12-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-21-028131","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774921028131/rdgdoc.xml","form_type":"4"}},{"id":2481329,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36554,"kind":"person","name":"NEWMAN MARK J","position":1,"cik":"0001242123","reported_name":"NEWMAN MARK J","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock (right to buy)","published_at":"2021-12-08T22:21:22.000Z","date":"2021-12-07","kind":"grant","acquired":true,"shares":25700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":25700,"derivative":{"exercise_price":3.82,"expiration_date":"2031-12-31","underlying":"Common Stock","underlying_shares":25700},"source":{"system":"sec-edgar","filing":"0001437749-21-028130","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774921028130/rdgdoc.xml","form_type":"4"}},{"id":2481326,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36555,"kind":"person","name":"Reynolds Mark","position":1,"cik":"0001298237","reported_name":"Reynolds Mark","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-08T22:20:37.000Z","date":"2021-12-07","kind":"grant","acquired":true,"shares":48200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":48200,"derivative":{"exercise_price":3.82,"expiration_date":"2031-12-07","underlying":"Common Stock","underlying_shares":48200},"source":{"system":"sec-edgar","filing":"0001437749-21-028129","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774921028129/rdgdoc.xml","form_type":"4"}},{"id":2481328,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36552,"kind":"person","name":"DODD DAVID A","position":1,"cik":"0001193607","reported_name":"DODD DAVID A","relationship":{"director":true,"officer":true,"officer_title":"President, CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-08T22:19:48.000Z","date":"2021-12-07","kind":"grant","acquired":true,"shares":103000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":103000,"derivative":{"exercise_price":3.82,"expiration_date":"2031-12-07","underlying":"Common Stock","underlying_shares":103000},"source":{"system":"sec-edgar","filing":"0001437749-21-028127","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774921028127/rdgdoc.xml","form_type":"4"}},{"id":2607658,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36552,"kind":"person","name":"DODD DAVID A","position":1,"cik":"0001193607","reported_name":"DODD DAVID A","relationship":{"director":true,"officer":true,"officer_title":"President, CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-11T21:38:08.000Z","date":"2021-08-11","kind":"grant","acquired":true,"shares":273000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted on December 2, 2020, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan.  Such approval was obtained on August 11, 2021, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":273000,"derivative":{"exercise_price":2.79,"expiration_date":"2030-12-02","underlying":"Common Stock","underlying_shares":273000},"source":{"system":"sec-edgar","filing":"0001437749-21-019510","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774921019510/rdgdoc.xml","form_type":"4"}},{"id":2607657,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36555,"kind":"person","name":"Reynolds Mark","position":1,"cik":"0001298237","reported_name":"Reynolds Mark","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-11T21:37:26.000Z","date":"2021-08-11","kind":"grant","acquired":true,"shares":128000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted on December 2, 2020, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan.  Such approval was obtained on August 11, 2021, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":128000,"derivative":{"exercise_price":2.79,"expiration_date":"2030-12-02","underlying":"Common Stock","underlying_shares":128000},"source":{"system":"sec-edgar","filing":"0001437749-21-019509","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774921019509/rdgdoc.xml","form_type":"4"}},{"id":2607656,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36554,"kind":"person","name":"NEWMAN MARK J","position":1,"cik":"0001242123","reported_name":"NEWMAN MARK J","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-11T21:36:26.000Z","date":"2021-08-11","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted on December 2, 2020, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan.  Such approval was obtained on August 11, 2021, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":35000,"derivative":{"exercise_price":2.79,"expiration_date":"2030-12-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001437749-21-019507","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774921019507/rdgdoc.xml","form_type":"4"}},{"id":2607655,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36558,"kind":"person","name":"Kollintzas Dean G","position":1,"cik":"0001378351","reported_name":"Kollintzas Dean G","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-08-11T21:35:08.000Z","date":"2021-08-11","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted on December 2, 2020, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan.  Such approval was obtained on August 11, 2021, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":25000,"derivative":{"exercise_price":2.79,"expiration_date":"2030-12-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-21-019506","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774921019506/rdgdoc.xml","form_type":"4"}},{"id":2607654,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36559,"kind":"person","name":"MCNALLY ROBERT T","position":1,"cik":"0001049435","reported_name":"MCNALLY ROBERT T","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-08-11T21:34:10.000Z","date":"2021-08-11","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted on December 2, 2020, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan.  Such approval was obtained on August 11, 2021, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":25000,"derivative":{"exercise_price":2.79,"expiration_date":"2030-12-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-21-019505","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774921019505/rdgdoc.xml","form_type":"4"}},{"id":2607653,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36557,"kind":"person","name":"CHASE RANDAL D","position":1,"cik":"0001078784","reported_name":"CHASE RANDAL D","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-08-11T21:33:22.000Z","date":"2021-08-11","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted on December 2, 2020, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan.  Such approval was obtained on August 11, 2021, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":25000,"derivative":{"exercise_price":2.79,"expiration_date":"2030-12-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-21-019504","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774921019504/rdgdoc.xml","form_type":"4"}},{"id":2607652,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-08-11T21:31:57.000Z","date":"2021-08-11","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted on December 2, 2020, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan.  Such approval was obtained on August 11, 2021, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":25000,"derivative":{"exercise_price":2.79,"expiration_date":"2030-12-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-21-019503","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774921019503/rdgdoc.xml","form_type":"4"}},{"id":3021264,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36555,"kind":"person","name":"Reynolds Mark","position":1,"cik":"0001298237","reported_name":"Reynolds Mark","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Stock Purchase Warrant","published_at":"2020-09-29T22:29:39.000Z","date":"2020-09-29","kind":"purchase","acquired":true,"shares":60184,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities are subject to a lock-up agreement, dated August 31, 2020, between the Reporting Person and Maxim Group LLC.  The securities may not be sold, exercised, or otherwise transferred prior to March 29, 2021, unless the restrictions are earlier waived by Maxim Group LLC or pursuant to specific exemptions in the lock-up agreement."}],"balance_after":60184,"derivative":{"exercise_price":5,"exercise_date":"2020-09-29","expiration_date":"2025-09-29","underlying":"Common Stock","underlying_shares":60184},"source":{"system":"sec-edgar","filing":"0001437749-20-020454","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774920020454/rdgdoc.xml","form_type":"4"}},{"id":3021263,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36555,"kind":"person","name":"Reynolds Mark","position":1,"cik":"0001298237","reported_name":"Reynolds Mark","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-09-29T22:29:39.000Z","date":"2020-09-29","kind":"purchase","acquired":true,"shares":60184,"price":5,"value":300920.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These securities are subject to a lock-up agreement, dated August 31, 2020, between the Reporting Person and Maxim Group LLC.  The securities may not be sold, exercised, or otherwise transferred prior to March 29, 2021, unless the restrictions are earlier waived by Maxim Group LLC or pursuant to specific exemptions in the lock-up agreement."}],"balance_after":60184,"source":{"system":"sec-edgar","filing":"0001437749-20-020454","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774920020454/rdgdoc.xml","form_type":"4"}},{"id":3021262,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36552,"kind":"person","name":"DODD DAVID A","position":1,"cik":"0001193607","reported_name":"DODD DAVID A","relationship":{"director":true,"officer":true,"officer_title":"President, CEO"}}],"security":"Common Stock Purchase Warrant","published_at":"2020-09-29T22:28:56.000Z","date":"2020-09-29","kind":"purchase","acquired":true,"shares":81870,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities are subject to a lock-up agreement, dated August 31, 2020, between the Reporting Person and Maxim Group LLC.  The securities may not be sold, exercised, or otherwise transferred prior to March 29, 2021, unless the restrictions are earlier waived by Maxim Group LLC or pursuant to specific exemptions in the lock-up agreement."}],"balance_after":81870,"derivative":{"exercise_price":5,"exercise_date":"2020-09-29","expiration_date":"2025-09-29","underlying":"Common Stock","underlying_shares":81870},"source":{"system":"sec-edgar","filing":"0001437749-20-020453","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774920020453/rdgdoc.xml","form_type":"4"}},{"id":3021261,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36552,"kind":"person","name":"DODD DAVID A","position":1,"cik":"0001193607","reported_name":"DODD DAVID A","relationship":{"director":true,"officer":true,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2020-09-29T22:28:56.000Z","date":"2020-09-29","kind":"purchase","acquired":true,"shares":81870,"price":5,"value":409350.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These securities are subject to a lock-up agreement, dated August 31, 2020, between the Reporting Person and Maxim Group LLC.  The securities may not be sold, exercised, or otherwise transferred prior to March 29, 2021, unless the restrictions are earlier waived by Maxim Group LLC or pursuant to specific exemptions in the lock-up agreement."}],"balance_after":81870,"source":{"system":"sec-edgar","filing":"0001437749-20-020453","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774920020453/rdgdoc.xml","form_type":"4"}},{"id":3021260,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36559,"kind":"person","name":"MCNALLY ROBERT T","position":1,"cik":"0001049435","reported_name":"MCNALLY ROBERT T","relationship":{"director":true}}],"security":"Common Stock Purchase Warrant","published_at":"2020-09-29T22:28:11.000Z","date":"2020-09-29","kind":"purchase","acquired":true,"shares":53925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities are subject to a lock-up agreement, dated August 31, 2020, between the Reporting Person and Maxim Group LLC.  The securities may not be sold, exercised, or otherwise transferred prior to March 29, 2021, unless the restrictions are earlier waived by Maxim Group LLC or pursuant to specific exemptions in the lock-up agreement."}],"balance_after":53925,"derivative":{"exercise_price":5,"exercise_date":"2020-09-29","expiration_date":"2025-09-29","underlying":"Common Stock","underlying_shares":53925},"source":{"system":"sec-edgar","filing":"0001437749-20-020452","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774920020452/rdgdoc.xml","form_type":"4"}},{"id":3021259,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36559,"kind":"person","name":"MCNALLY ROBERT T","position":1,"cik":"0001049435","reported_name":"MCNALLY ROBERT T","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-09-29T22:28:11.000Z","date":"2020-09-29","kind":"purchase","acquired":true,"shares":53925,"price":5,"value":269625.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These securities are subject to a lock-up agreement, dated August 31, 2020, between the Reporting Person and Maxim Group LLC.  The securities may not be sold, exercised, or otherwise transferred prior to March 29, 2021, unless the restrictions are earlier waived by Maxim Group LLC or pursuant to specific exemptions in the lock-up agreement."}],"balance_after":53925,"source":{"system":"sec-edgar","filing":"0001437749-20-020452","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774920020452/rdgdoc.xml","form_type":"4"}},{"id":3021258,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true}}],"security":"Common Stock Purchase Warrant","published_at":"2020-09-29T22:27:27.000Z","date":"2020-09-29","kind":"purchase","acquired":true,"shares":21024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities are subject to a lock-up agreement, dated August 31, 2020, between the Reporting Person and Maxim Group LLC.  The securities may not be sold, exercised, or otherwise transferred prior to March 29, 2021, unless the restrictions are earlier waived by Maxim Group LLC or pursuant to specific exemptions in the lock-up agreement."}],"balance_after":21024,"derivative":{"exercise_price":5,"exercise_date":"2020-09-29","expiration_date":"2025-09-29","underlying":"Common Stock","underlying_shares":21024},"source":{"system":"sec-edgar","filing":"0001437749-20-020451","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774920020451/rdgdoc.xml","form_type":"4"}},{"id":3021257,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-09-29T22:27:27.000Z","date":"2020-09-29","kind":"purchase","acquired":true,"shares":21024,"price":5,"value":105120.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These securities are subject to a lock-up agreement, dated August 31, 2020, between the Reporting Person and Maxim Group LLC.  The securities may not be sold, exercised, or otherwise transferred prior to March 29, 2021, unless the restrictions are earlier waived by Maxim Group LLC or pursuant to specific exemptions in the lock-up agreement."}],"balance_after":21024,"source":{"system":"sec-edgar","filing":"0001437749-20-020451","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774920020451/rdgdoc.xml","form_type":"4"}},{"id":3021254,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36558,"kind":"person","name":"Kollintzas Dean G","position":1,"cik":"0001378351","reported_name":"Kollintzas Dean G","relationship":{"director":true}}],"security":"Common Stock Purchase Warrant","published_at":"2020-09-29T22:26:32.000Z","date":"2020-09-29","kind":"purchase","acquired":true,"shares":11987,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These securities are subject to a lock-up agreement, dated August 31, 2020, between the Reporting Person and Maxim Group LLC.  The securities may not be sold, exercised, or otherwise transferred prior to March 29, 2021, unless the restrictions are earlier waived by Maxim Group LLC or pursuant to specific exemptions in the lock-up agreement."}],"balance_after":11987,"derivative":{"exercise_price":5,"exercise_date":"2020-09-29","expiration_date":"2025-09-29","underlying":"Common Stock","underlying_shares":11987},"source":{"system":"sec-edgar","filing":"0001437749-20-020450","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774920020450/rdgdoc.xml","form_type":"4"}},{"id":3021253,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36558,"kind":"person","name":"Kollintzas Dean G","position":1,"cik":"0001378351","reported_name":"Kollintzas Dean G","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-09-29T22:26:32.000Z","date":"2020-09-29","kind":"purchase","acquired":true,"shares":11987,"price":5,"value":59935.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These securities are subject to a lock-up agreement, dated August 31, 2020, between the Reporting Person and Maxim Group LLC.  The securities may not be sold, exercised, or otherwise transferred prior to March 29, 2021, unless the restrictions are earlier waived by Maxim Group LLC or pursuant to specific exemptions in the lock-up agreement."}],"balance_after":11987,"source":{"system":"sec-edgar","filing":"0001437749-20-020450","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774920020450/rdgdoc.xml","form_type":"4"}},{"id":3021256,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36557,"kind":"person","name":"CHASE RANDAL D","position":1,"cik":"0001078784","reported_name":"CHASE RANDAL D","relationship":{"director":true}}],"security":"Common Stock Purchase Warrant","published_at":"2020-09-29T22:19:51.000Z","date":"2020-09-29","kind":"purchase","acquired":true,"shares":16613,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities are subject to a lock-up agreement, dated August 31, 2020, between the Reporting Person and Maxim Group LLC.  The securities may not be sold, exercised, or otherwise transferred prior to March 29, 2021, unless the restrictions are earlier waived by Maxim Group LLC or pursuant to specific exemptions in the lock-up agreement."}],"balance_after":16613,"derivative":{"exercise_price":5,"exercise_date":"2020-09-29","expiration_date":"2025-09-29","underlying":"Common Stock","underlying_shares":16613},"source":{"system":"sec-edgar","filing":"0001437749-20-020449","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774920020449/rdgdoc.xml","form_type":"4"}},{"id":3021255,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36557,"kind":"person","name":"CHASE RANDAL D","position":1,"cik":"0001078784","reported_name":"CHASE RANDAL D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-09-29T22:19:51.000Z","date":"2020-09-29","kind":"purchase","acquired":true,"shares":16613,"price":5,"value":83065.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These securities are subject to a lock-up agreement, dated August 31, 2020, between the Reporting Person and Maxim Group LLC.  The securities may not be sold, exercised, or otherwise transferred prior to March 29, 2021, unless the restrictions are earlier waived by Maxim Group LLC or pursuant to specific exemptions in the lock-up agreement."}],"balance_after":16613,"source":{"system":"sec-edgar","filing":"0001437749-20-020449","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774920020449/rdgdoc.xml","form_type":"4"}},{"id":3725678,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36561,"kind":"person","name":"SPENCER JOHN N JR","position":1,"cik":"0001270555","reported_name":"SPENCER JOHN N JR","relationship":{"director":true}}],"security":"Common Stock Purchase Option","published_at":"2018-12-19T20:39:51.000Z","date":"2018-12-17","kind":"grant","acquired":true,"shares":345000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":345000,"derivative":{"exercise_price":0.0266,"expiration_date":"2028-12-17","underlying":"Common Stock","underlying_shares":345000},"source":{"system":"sec-edgar","filing":"0001437749-18-022299","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774918022299/rdgdoc.xml","form_type":"4"}},{"id":3725676,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36559,"kind":"person","name":"MCNALLY ROBERT T","position":1,"cik":"0001049435","reported_name":"MCNALLY ROBERT T","relationship":{"director":true}}],"security":"Common Stock Purchase Option","published_at":"2018-12-19T20:39:36.000Z","date":"2018-12-17","kind":"grant","acquired":true,"shares":650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":650000,"derivative":{"exercise_price":0.0266,"expiration_date":"2028-12-17","underlying":"Common Stock","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0001437749-18-022298","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774918022298/rdgdoc.xml","form_type":"4"}},{"id":3725675,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36558,"kind":"person","name":"Kollintzas Dean G","position":1,"cik":"0001378351","reported_name":"Kollintzas Dean G","relationship":{"director":true}}],"security":"Common Stock Purchase Option","published_at":"2018-12-19T20:39:20.000Z","date":"2018-12-17","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":300000,"derivative":{"exercise_price":0.0266,"expiration_date":"2028-12-17","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001437749-18-022297","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774918022297/rdgdoc.xml","form_type":"4"}},{"id":3725673,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36557,"kind":"person","name":"CHASE RANDAL D","position":1,"cik":"0001078784","reported_name":"CHASE RANDAL D","relationship":{"director":true}}],"security":"Common Stock Purchase Option","published_at":"2018-12-19T20:39:05.000Z","date":"2018-12-17","kind":"grant","acquired":true,"shares":320000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":320000,"derivative":{"exercise_price":0.0266,"expiration_date":"2028-12-17","underlying":"Common Stock","underlying_shares":320000},"source":{"system":"sec-edgar","filing":"0001437749-18-022296","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774918022296/rdgdoc.xml","form_type":"4"}},{"id":3725674,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":161670,"kind":"person","name":"ROBINSON HARRIET L","position":1,"cik":"0001377780","reported_name":"ROBINSON HARRIET L","relationship":{"director":true,"officer":true,"officer_title":"CSO Emeritus"}}],"security":"Common Stock Purchase Option","published_at":"2018-12-19T20:38:45.000Z","date":"2018-12-17","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":600000,"derivative":{"exercise_price":0.0266,"expiration_date":"2028-12-17","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001437749-18-022295","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774918022295/rdgdoc.xml","form_type":"4"}},{"id":3725672,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36555,"kind":"person","name":"Reynolds Mark","position":1,"cik":"0001298237","reported_name":"Reynolds Mark","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Stock Purchase Option","published_at":"2018-12-19T20:38:19.000Z","date":"2018-12-17","kind":"grant","acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":750000,"derivative":{"exercise_price":0.0266,"expiration_date":"2028-12-17","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001437749-18-022294","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774918022294/rdgdoc.xml","form_type":"4"}},{"id":3725671,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":124199,"kind":"person","name":"Guirakhoo Farshad","position":1,"cik":"0001656602","reported_name":"Guirakhoo Farshad","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock Purchase Option","published_at":"2018-12-19T20:31:55.000Z","date":"2018-12-17","kind":"grant","acquired":true,"shares":625000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":625000,"derivative":{"exercise_price":0.0266,"expiration_date":"2028-12-17","underlying":"Common Stock","underlying_shares":625000},"source":{"system":"sec-edgar","filing":"0001437749-18-022291","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774918022291/rdgdoc.xml","form_type":"4"}},{"id":3725670,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":36552,"kind":"person","name":"DODD DAVID A","position":1,"cik":"0001193607","reported_name":"DODD DAVID A","relationship":{"director":true,"officer":true,"officer_title":"President, CEO"}}],"security":"Common Stock Purchase Option","published_at":"2018-12-19T20:27:54.000Z","date":"2018-12-17","kind":"grant","acquired":true,"shares":785000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant."}],"balance_after":785000,"derivative":{"exercise_price":0.0266,"expiration_date":"2028-12-17","underlying":"Common Stock","underlying_shares":785000},"source":{"system":"sec-edgar","filing":"0001437749-18-022288","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774918022288/rdgdoc.xml","form_type":"4"}}],"next_cursor":"2018-12-19T20:27:54.000000Z,3725670"}